[Fibrinogen metabolism in congestive circulatory insufficiency].
Using 125I-labelled fibrinogen the metabolism of this protein was studied in 29 patients with II-III stage congestive circulatory insufficiency due to ischemic heart disease and rheumatic heart diseases. It was established that with the progression of circulatory insufficiency fibrinogen half-life increased. The body content of total fibrinogen increased with the gradual intensification of circulatory insufficiency due to growth of the extravascular (noncirculating) fraction. The growth is associated with the intensified egress of circulating fibrinogen into the extravascular space (thrombus, tissue, etc.). The role of disseminated intravascular clotting and consumption coagulopathy in the pathogenesis of congestive circulatory failure is discussed.
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000097:blood; D001825:Body Fluid Compartments; D003327:Coronary Disease / Q000097:blood; D005340:Fibrinogen / Q000378:metabolism*; D006207:Half-Life; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D007457:Iodine Radioisotopes; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000097:blood; D012214:Rheumatic Heart Disease / Q000097:blood
D007457:Iodine Radioisotopes; D005340:Fibrinogen
Metabolizm fibrinogena pri zastoĭnoĭ nedostatochnosti krovoobrashcheniia.